World AIDS Day: India’s HIV Response Timeline
Explore India's HIV response timeline from the first reported case in 1986 to NACP, free ART, the 2017 HIV Act, viral suppression and India's 2027
Latest Story
India detected its first HIV case in 1986, among female sex workers in Chennai. Four decades, five National AIDS Control Programme phases and one law later, the India HIV Estimation 2025 report puts adult HIV prevalence at just 0.20% — yet an estimated 25.61 lakh people were still living with HIV in 2024. This is the dated record of how India built its HIV response, from surveillance and free antiretroviral treatment to a 2017 rights law and a 2027 epidemic-control target.
🧠 AI Overview Summary
India recorded its first HIV case in 1986 in Chennai and launched its first National AIDS Control Programme (NACP-I) in 1992 through the National AIDS Control Organisation (NACO). Free antiretroviral therapy (ART) began in 2004, the HIV and AIDS (Prevention and Control) Act became law in 2017, and routine viral-load testing started in 2018. NACP-V, running 2021–2026 with an outlay of ₹15,471.94 crore, targets prevention, detection and treatment aligned with SDG 3.3. The India HIV Estimation 2025 report puts 2024 adult HIV prevalence at 0.20% and 25.61 lakh people living with HIV, with new infections down 48.7% and AIDS-related deaths down 81.4% since 2010. In 2026 NACO identified 219 high-priority districts as part of Mission AIDS Suraksha, targeting HIV epidemic control by 1 December 2027.
India’s HIV Response: Key Questions
Four Decades of India’s HIV Response, in Eight Lines
- India’s first HIV case surfaced in 1986 among female sex workers in Chennai — the same year the Government formed the National AIDS Committee.
- NACP-I (1992) built the basic machinery: NACO, surveillance, blood safety and awareness, before any treatment programme existed.
- Free ART since 2004 changed the meaning of a diagnosis — from a progressive terminal illness toward a manageable long-term condition for those who stay on treatment.
- The 2017 HIV and AIDS (Prevention and Control) Act made India’s response a legal rights issue, not only a medical one, with state Ombudsmen and anti-discrimination protections.
- National prevalence has fallen sharply: new infections down 48.7% and AIDS-related deaths down 81.4% between 2010 and 2024.
- 25.61 lakh people were still estimated to be living with HIV in 2024 even as adult prevalence sits at a low 0.20%.
- The epidemic is not geographically uniform: Mizoram and Nagaland exceed 1% adult prevalence, and some states show rising trends.
- NACP-V (2021–2026) and Mission AIDS Suraksha now target 219 high-priority districts, aiming for HIV epidemic control by 1 December 2027.
Five Eras of India’s HIV Response
From a single Chennai diagnosis to a district-targeted epidemic-control push, India’s response moved through five distinct phases.
Discovery
The virus arrives in India’s public-health consciousness. The central question: how big is the problem, and where is it spreading?
Build the System
NACP-I and NACP-II, NACO, surveillance, blood-safety systems and targeted prevention expand nationwide.
Treatment Changes Everything
Free ART begins in 2004 and expands rapidly under NACP-III’s “Halt and Reverse” mandate from 2007.
Rights + Viral Suppression
NACP-IV, the 2017 HIV/AIDS Act, Test-and-Treat and routine viral-load monitoring reshape the programme around measurable outcomes.
Find the Remaining Gaps
NACP-V and Mission AIDS Suraksha increasingly target high-priority districts, aiming for epidemic control by 2027.
India’s first HIV case was identified in 1986 among female sex workers in Chennai, Tamil Nadu, according to NACO. The same year, the Government established the National AIDS Committee under the Ministry of Health and Family Welfare. HIV was no longer a distant international health story — the country needed a system capable of understanding where the virus was spreading and how to respond, which arrived six years later as NACP-I.
The 2017 law was a turning point in a different sense. Effective ART could suppress the virus, but medicine alone could not eliminate the consequences of stigma. The HIV and AIDS (Prevention and Control) Act, enacted 20 April 2017 and in force from 10 September 2018, provides legal protections against discrimination and confidentiality breaches, with state-level Ombudsmen and Complaints Officers — formally making India’s HIV response a rights issue as well as a medical one.
The HIV Treatment Cascade: 95-95-95
Modern HIV control is measured less by test counts and more by how many people move all the way through the chain from diagnosis to viral suppression.
What 95-95-95 Means
- First 95: 95% of people living with HIV know their status.
- Second 95: 95% of those who know their status receive ART.
- Third 95: 95% of those on ART achieve viral suppression.
- NACP-V built its treatment-continuum targets around this framework, moving year-by-year toward at least 95% across the cascade.
- In 2026, Indian officials have discussed an enhanced 95:95:99 ambition for the next programme cycle.
HIV is not the same as AIDS. HIV is the virus; AIDS refers to the advanced disease stage associated with severe immune-system damage. NACO states that HIV infection is not the end of life, and that effective ART can suppress viral replication and help prevent disease progression — a distinction that reframes the story from “infection → AIDS → death” to “testing → treatment → viral suppression → long-term care.” One broken link in that chain — someone who never tests, tests but never starts ART, or starts ART but is lost to follow-up — is why the cascade, not the raw test count, is the measure that matters.
India’s HIV Response Timeline
Newest first — the milestones that shaped how India detects, treats and protects the rights of people living with HIV.
Target: HIV Epidemic Control by World AIDS Day
Target: In 2026 the Government of India said it is targeting HIV epidemic control by 1 December 2027, supported by Mission AIDS Suraksha and intensified action in 219 high-priority districts.
219 High-Priority Districts Identified
Shift: NACO identified 219 high-priority districts for intensified HIV interventions — early diagnosis, treatment linkage, retention and viral suppression — moving the response from a national strategy to district-level control.
India HIV Estimation 2025 Published
Findings: An estimated 25.61 lakh people were living with HIV in 2024; adult prevalence (age 15–49) was 0.20%. New infections fell about 48.7% and AIDS-related deaths fell about 81.4% since 2010. Mizoram and Nagaland exceeded 1% adult prevalence, with rising trends flagged in parts of the Northeast and Punjab.
NACP-V Launched
Outcome: The National AIDS and STD Control Programme Phase-V began, approved with an outlay of ₹15,471.94 crore through March 2026, built around Test and Treat, universal viral-load testing, Mission Sampark, community-based screening and Dolutegravir-based treatment.
HIV and AIDS (Prevention and Control) Act
Outcome: The Act provides legal protection against HIV-related discrimination and breaches of confidentiality, establishing state-level Ombudsmen and Complaints Officers. Test-and-Treat policy (2017) and routine viral-load testing (2018) followed in the same window, shifting the programme from “start ART” toward “confirm the virus is suppressed.”
NACP-IV Begins
Outcome: NACP-IV focused on consolidating earlier gains while accelerating prevention among key and vulnerable populations, comprehensive care and treatment, and building strategic-information capacity across states.
NACP-III: “Halt and Reverse”
Outcome: NACP-III set a goal to halt and reverse the epidemic through two pillars — targeted prevention among higher-risk populations, and expanded care, support and treatment — while strengthening State AIDS Control Societies and District AIDS Prevention and Control Units.
Free Antiretroviral Treatment Begins
Outcome: India launched free ART in eight tertiary hospitals across six high-prevalence states and Delhi. The programme later expanded nationwide, covering first-, second- and third-line treatment plus prevention-of-parent-to-child-transmission and opportunistic-infection services.
NACP-II Launched
Outcome: NACP-II moved beyond awareness toward targeted interventions, expanded surveillance, counselling and testing, prevention of parent-to-child transmission, blood-safety measures and State AIDS Control Societies — recognising HIV patterns differed by state and community.
NACP-I and NACO Established
Outcome: India launched its first National AIDS Control Programme and created the National AIDS Control Organisation (NACO) to implement it, focused on awareness generation, HIV surveillance, blood safety and basic institutional capacity.
India’s First HIV Case
Outcome: India’s first HIV case was identified in 1986, according to NACO. The same year, the Government established the National AIDS Committee under the Ministry of Health and Family Welfare.
The Geography of HIV in India
A national average of 0.20% hides substantial state-level variation — the 2025 estimation found several states well above that line.
| State / Category | 2024 Adult Prevalence | Note |
|---|---|---|
| Mizoram | Above 1% | Among the highest state-level prevalence in India |
| Nagaland | Above 1% | Among the highest state-level prevalence in India |
| Manipur | ≈0.81% | Historically high-prevalence Northeast state |
| Andhra Pradesh | 0.40%–1% | Long-standing higher-prevalence southern state |
| Karnataka | 0.40%–1% | Long-standing higher-prevalence southern state |
| Punjab | 0.40%–1% | Flagged with a rising epidemic trend |
| Telangana | 0.40%–1% | Long-standing higher-prevalence southern state |
| Meghalaya | 0.40%–1% | Northeast state above national average |
| National average | 0.20% | Adult (age 15–49) prevalence, India HIV Estimation 2025 |
⚠️ Editorial Note
State-level prevalence bands and the finding of rising trends in parts of the Northeast and Punjab are drawn from the India HIV Estimation 2025 technical report. A falling national average does not mean every state, district or population is experiencing the same trend — that is precisely why NACO’s 2026 response shifted toward naming 219 high-priority districts by name rather than relying on the national figure alone.
India’s Five NACP Phases
Each National AIDS Control Programme phase answered a different question about the epidemic.
| Phase | Period | Primary Focus |
|---|---|---|
| NACP-I | 1992–1999 | Awareness, HIV surveillance, blood safety, institutional capacity (NACO created) |
| NACP-II | 1999–2007 | Targeted interventions, State AIDS Control Societies, prevention of parent-to-child transmission |
| NACP-III | 2007–2012 | “Halt and Reverse” — prevention among higher-risk groups plus expanded care and treatment |
| NACP-IV | 2012–2021 | Consolidation, key/vulnerable population prevention, comprehensive treatment, strategic information |
| NACP-V | 2021–2026 | Prevention + Detection + Treatment; ₹15,471.94 crore outlay; SDG 3.3 aligned |
Explore More Timelines
People Also Ask
Frequently Asked Questions
Related AiTimeline Stories
Sources & Further Reading
⚠️ Editorial Note
Epidemiological figures are drawn from NACO’s India HIV Estimation 2025 technical report and labelled with their 2024 estimate year; they should not be mixed with older NACO estimation rounds as though directly comparable, since NACO’s methodology is periodically revised. This timeline compiles publicly available NACO, UNAIDS and WHO records. It is editorial and AI-assisted content, not an official Government of India, NACO or WHO communication; figures and dates are provided for reference and may contain inaccuracies despite verification efforts.